Skip to main content

Table 1 The patient’s laboratory findings prior to receiving treatment

From: Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)–CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report

WBC

5800

/μL

CRP

<0.10

mg/dl

RBC

404 × 104

/μL

LDH

238

U/L

Hb

13.5

g/dL

UA

5.8

mg/dL

Plt

16.7 × 104

/μL

BUN

12.6

mg/dL

PT

11.7

sec

Cr

0.52

mg/dL

AST

41

IU/L

Na

141

mEq/l

ALT

46

IU/L

K

3.8

mEq/l -

TP

7.6

g/dL

HBsAg

(−)

-

Alb

4.4

g/dL

HCVAb

(+)

-

TBIL

0.5

mg/dL

HCV-RNA

6.3

LogIU/ml

ALP

248

IU/L

Genotype

1B

 

γ-GTP

20

IU/L

   
  1. WBC, white blood cells; RBC, red blood cells; Plt, platelets; PT, prothrombin time; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TP, total protein; Alb, albumin; TBIL, total bilirubin; ALP, alkaline phosphatase; γ-GTP, gamma glutamyl transpeptidase; CRP, C-reactive protein; LDH, lactate dehydrogenase; UA, uric acid; BUN, blood urea nitrogen; Cr, creatinine; Na, natrium; K, potasium; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus antibody; HCV-RNA, hepatitis C virus ribonucleic acid.